B-type natriuretic peptide


Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.
Related to B-type natriuretic peptide: Brain natriuretic peptide

B-type natriuretic peptide (BNP),

cardiac neurohormone secreted by the left ventricle in response to elevated volume and pressure, leading to dilated blood vessels and sodium and water loss.

brain natriuretic peptide

An atrial natriuretic peptide-like brain peptide produced predominantly in the cerebral ventricles, which induces diuresis and is secreted in response to fluid overload, as occurs in congestive heart failure.

B-type natriuretic peptide

See BNP.

B-type natriuretic peptide

See NATRIURETIC PEPTIDE.
References in periodicals archive ?
Usefulness of B-type natriuretic peptide in hypertensive patients with exertional dyspnea and normal left ventricular ejection fraction and correlation with new echocardiographic indexes of systolic and diastolic function.
B-type natriuretic peptide (BNP) and proBNP: role of emerging markers to guide therapy and determine prognosis in cardiovascular disorders.
Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.
B-type natriuretic peptide level fell from a mean of 329 pg/mL to 281 pg/mL in the tai chi group, and rose from a mean of 285 pg/mL to 306 pg/mL in the control group.
By contrast, proB-type natriuretic peptide measures N-terminal proB-type natriuretic peptide (NT-proB-type natriuretic peptide), which is released when B-type natriuretic peptide is cleaved from its precursor, proB-type natriuretic peptide.
B-Type Natriuretic peptide for the evaluation of volume status in elderly postoperative patients.
The HABIT study, a multi-center, single-arm, double-blinded observational prospective clinical trial, was designed to monitor daily concentrations of B-type natriuretic peptide (BNP) and determine the extent to which they correlate with ADHF and related adverse outcomes.
Plasma levels of B-type natriuretic peptide (BNP) did not differ significantly from those in diabetic people without any left ventricular dysfunction, so "BNP may not be useful as a screening tool for diabetic cardiomyopathy," he said at the meeting.
They used blood tests for two molecules released by the heart when damaged or under stress, called high sensitivity troponin and B-type natriuretic peptide.
Those include obese patients, patients with kidney failure and patients with an intermediate level of b-type natriuretic peptide, a biomarker which has been associated with acute heart failure and cardiovascular risk.